800 related articles for article (PubMed ID: 27223840)
1. Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.
Reuland EA; Sonder GJ; Stolte I; Al Naiemi N; Koek A; Linde GB; van de Laar TJ; Vandenbroucke-Grauls CM; van Dam AP
Clin Microbiol Infect; 2016 Aug; 22(8):731.e1-7. PubMed ID: 27223840
[TBL] [Abstract][Full Text] [Related]
2. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
[TBL] [Abstract][Full Text] [Related]
3. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study.
Arcilla MS; van Hattem JM; Haverkate MR; Bootsma MCJ; van Genderen PJJ; Goorhuis A; Grobusch MP; Lashof AMO; Molhoek N; Schultsz C; Stobberingh EE; Verbrugh HA; de Jong MD; Melles DC; Penders J
Lancet Infect Dis; 2017 Jan; 17(1):78-85. PubMed ID: 27751772
[TBL] [Abstract][Full Text] [Related]
4. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors.
Ostholm-Balkhed A; Tärnberg M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A;
J Antimicrob Chemother; 2013 Sep; 68(9):2144-53. PubMed ID: 23674762
[TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) - Data of a prospective traveller study.
Kantele A; Mero S; Kirveskari J; Lääveri T
Travel Med Infect Dis; 2017; 16():23-30. PubMed ID: 28153711
[TBL] [Abstract][Full Text] [Related]
6. Extended-spectrum β-lactamase-producing Enterobacteriaceae colonisation in long-term overseas business travellers.
Mizuno Y; Miura Y; Yamaguchi T; Matsumoto T
Travel Med Infect Dis; 2016; 14(6):561-567. PubMed ID: 27769900
[TBL] [Abstract][Full Text] [Related]
7. High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors.
Kuenzli E; Jaeger VK; Frei R; Neumayr A; DeCrom S; Haller S; Blum J; Widmer AF; Furrer H; Battegay M; Endimiani A; Hatz C
BMC Infect Dis; 2014 Oct; 14():528. PubMed ID: 25270732
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae.
Kantele A; Lääveri T; Mero S; Vilkman K; Pakkanen SH; Ollgren J; Antikainen J; Kirveskari J
Clin Infect Dis; 2015 Mar; 60(6):837-46. PubMed ID: 25613287
[TBL] [Abstract][Full Text] [Related]
9. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies.
Lääveri T; Vlot JA; van Dam AP; Häkkinen HK; Sonder GJB; Visser LG; Kantele A
BMC Infect Dis; 2018 Jul; 18(1):341. PubMed ID: 30037325
[TBL] [Abstract][Full Text] [Related]
10. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
Hirakata Y; Matsuda J; Miyazaki Y; Kamihira S; Kawakami S; Miyazawa Y; Ono Y; Nakazaki N; Hirata Y; Inoue M; Turnidge JD; Bell JM; Jones RN; Kohno S;
Diagn Microbiol Infect Dis; 2005 Aug; 52(4):323-9. PubMed ID: 16165001
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and genetic diversity of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in nursing homes in Bavaria, Germany.
Valenza G; Nickel S; Pfeifer Y; Pietsch M; Voigtländer E; Lehner-Reindl V; Höller C
Vet Microbiol; 2017 Feb; 200():138-141. PubMed ID: 26494113
[TBL] [Abstract][Full Text] [Related]
12. International travel is a risk factor for extended-spectrum β-lactamase-producing Enterobacteriaceae acquisition in children: A case-case-control study in an urban U.S. hospital.
Strysko JP; Mony V; Cleveland J; Siddiqui H; Homel P; Gagliardo C
Travel Med Infect Dis; 2016; 14(6):568-571. PubMed ID: 27890813
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam.
Reuland EA; Al Naiemi N; Kaiser AM; Heck M; Kluytmans JA; Savelkoul PH; Elders PJ; Vandenbroucke-Grauls CM
J Antimicrob Chemother; 2016 Apr; 71(4):1076-82. PubMed ID: 26755493
[TBL] [Abstract][Full Text] [Related]
14. Current status of extended spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis in Okinawa prefecture, Japan.
Nakama R; Shingaki A; Miyazato H; Higa R; Nagamoto C; Hamamoto K; Ueda S; Hachiman T; Touma Y; Miyagi K; Kawahara R; Toyosato T; Hirai I
J Infect Chemother; 2016 May; 22(5):281-6. PubMed ID: 26898665
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia.
Vlieghe ER; Huang TD; Phe T; Bogaerts P; Berhin C; De Smet B; Peetermans WE; Jacobs JA; Glupczynski Y
Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1223-9. PubMed ID: 25717021
[TBL] [Abstract][Full Text] [Related]
16. High carriage rate of ESBL-producing Enterobacteriaceae at presentation and follow-up among travellers with gastrointestinal complaints returning from India and Southeast Asia.
Barreto Miranda I; Ignatius R; Pfüller R; Friedrich-Jänicke B; Steiner F; Paland M; Dieckmann S; Schaufler K; Wieler LH; Guenther S; Mockenhaupt FP
J Travel Med; 2016 Feb; 23(2):tav024. PubMed ID: 26858272
[TBL] [Abstract][Full Text] [Related]
17. High Gastrointestinal Colonization Rate with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia.
Desta K; Woldeamanuel Y; Azazh A; Mohammod H; Desalegn D; Shimelis D; Gulilat D; Lamisso B; Makonnen E; Worku A; Mannerqvist K; Struwe J; Aspevall O; Aklillu E
PLoS One; 2016; 11(8):e0161685. PubMed ID: 27574974
[TBL] [Abstract][Full Text] [Related]
18. Duration of travel-associated faecal colonisation with ESBL-producing Enterobacteriaceae - A one year follow-up study.
ÖstholmBalkhed Å; Tärnberg M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A;
PLoS One; 2018; 13(10):e0205504. PubMed ID: 30356258
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK.
Hopkins KL; Mushtaq S; Richardson JF; Doumith M; de Pinna E; Cheasty T; Wain J; Livermore DM; Woodford N
Int J Antimicrob Agents; 2014 May; 43(5):431-7. PubMed ID: 24661532
[TBL] [Abstract][Full Text] [Related]
20. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
